RAI14 Antibody (C-term) Blocking Peptide

RAI14 Antibody (C-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP6233a
Catalog Number: AC-BP6233a
Size: 500 µg
Datasheet
Request Information
Background:
Retinoic acid plays a critical role in development, cellular growth, and differentiation and induces the expression of a variety of genes. RAI14 is expressed in retinal pigment epithelial cells, induced by all-trans-retinoic acid. Highest expression of RAI14 occurs in the placenta and testis. The predicted human RAI14 protein consists of 980 amino acids, and features 6 potential N-glycosylation sites, six ankyrin repeats and several coiled-coil helical domains. RAI14, which localizes to the cytoplasm, is also highly expressed in several human cancer cell lines. The precise cellular function of RAI14 remains to be determined.

Other Names:
Ankycorbin, Ankyrin repeat and coiled-coil structure-containing protein, Novel retinal pigment epithelial cell protein, Retinoic acid-induced protein 14, RAI14, KIAA1334, NORPEG

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6233a was selected from the C-term region of human RAI14 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: RAI14

Gene ID: 26064
Primary Accession: Q9P0K7
Other Accession: NP_056392
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:RAI14 Antibody (C-term) Blocking Peptide